Sally Greenberg

788 total citations
19 papers, 489 citations indexed

About

Sally Greenberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sally Greenberg has authored 19 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Sally Greenberg's work include HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (6 papers). Sally Greenberg is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Cancer Treatment Studies (6 papers). Sally Greenberg collaborates with scholars based in Australia, United States and Cyprus. Sally Greenberg's co-authors include Gary L. Snyder, Hope S. Rugo, Arthur S. Brown, Daniel Malamud, Jimmy Hwang, Michelle Melisko, John W. Park, Laura F. Petrillo, Mark M. Moasser and Andrei Goga and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Sally Greenberg

18 papers receiving 478 citations

Peers

Sally Greenberg
Laura L. Benzonana United Kingdom
Paulo L. Pfitzinger Germany
Deborah A. Silverman United States
Toshinari Meguro Japan
Dihan Lu China
Anna‐Laura Potthoff Germany
Evert C. A. Kaal Netherlands
Toshiaki Mishima Japan
Andrej Vranič Slovenia
J. J. Wang Taiwan
Laura L. Benzonana United Kingdom
Sally Greenberg
Citations per year, relative to Sally Greenberg Sally Greenberg (= 1×) peers Laura L. Benzonana

Countries citing papers authored by Sally Greenberg

Since Specialization
Citations

This map shows the geographic impact of Sally Greenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Greenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Greenberg more than expected).

Fields of papers citing papers by Sally Greenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Greenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Greenberg. The network helps show where Sally Greenberg may publish in the future.

Co-authorship network of co-authors of Sally Greenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Greenberg. A scholar is included among the top collaborators of Sally Greenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Greenberg. Sally Greenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lok, Sheau Wen, Richard de Boer, Laeeq Malik, et al.. (2023). Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer. Breast Cancer Research and Treatment. 198(1). 67–74. 7 indexed citations
2.
Lok, Sheau Wen, A. Antón, Sally Baron‐Hay, et al.. (2023). Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry.. Journal of Clinical Oncology. 41(16_suppl). e13054–e13054. 1 indexed citations
3.
Wong, Vanessa, Richard de Boer, Belinda Yeo, et al.. (2022). Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study. Clinical Breast Cancer. 22(7). e764–e772. 1 indexed citations
4.
Vidula, Neelima, Sally Greenberg, Laura F. Petrillo, et al.. (2021). Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid. npj Breast Cancer. 7(1). 113–113. 16 indexed citations
5.
Antón, A., Rachel Wong, Sheau Wen Lok, et al.. (2021). Abstract PS6-35: Real world outcomes in elderly women with HER2 positive advanced breast cancer. Cancer Research. 81(4_Supplement). PS6–35. 1 indexed citations
6.
Kanjanapan, Yada, Sheau Wen Lok, Peter Gibbs, et al.. (2020). Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer. Breast Cancer Research and Treatment. 184(1). 87–95. 3 indexed citations
7.
Boer, Richard H. De, Sheau Wen Lok, Peter Gibbs, et al.. (2020). Real‐world impact of anti‐HER2 therapy‐related cardiotoxicity in patients with advanced HER2‐positive breast cancer. Asia-Pacific Journal of Clinical Oncology. 16(6). 356–362. 2 indexed citations
8.
Evans, N., A. Antón, Rachel Wong, et al.. (2020). 51P Real world outcomes in elderly women with HER2-positive advanced breast cancer. Annals of Oncology. 31. S1262–S1262. 2 indexed citations
9.
Lok, Sheau Wen, Richard H. De Boer, Laeeq Malik, et al.. (2020). Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer.. Journal of Clinical Oncology. 38(15_suppl). 1038–1038. 2 indexed citations
10.
Greenberg, Sherry A., et al.. (2018). NICHE (Nurses Improving Care for Healthsystem Elders) Program: Long Term Care. Journal of the American Medical Directors Association. 19(3). B12–B13. 1 indexed citations
11.
Vidula, Neelima, Jimmy Hwang, Sally Greenberg, et al.. (2017). Long term follow up (LTFU) of adjuvant zoledronic acid (ZOL) in high risk early stage breast cancer (ESBC) defined by bone marrow (BM) disseminated tumor cells (DTC).. Journal of Clinical Oncology. 35(15_suppl). e12001–e12001. 1 indexed citations
12.
Wu, Justine, et al.. (2012). “Breaking the cycle of adolescent pregnancy: can mothers influence their daughters' contraceptive behavior?”. Contraception. 86(2). 186–186. 1 indexed citations
13.
Greenberg, Sally, Alison Stopeck, & Hope S. Rugo. (2011). Systemic treatment of early breast cancer—a biological perspective. Journal of Surgical Oncology. 103(6). 619–626. 7 indexed citations
14.
Greenberg, Sally & Hope S. Rugo. (2010). Triple-Negative Breast Cancer. The Cancer Journal. 16(1). 33–38. 57 indexed citations
15.
Snyder, Gary L. & Sally Greenberg. (2010). Effect of anaesthetic technique and other perioperative factors on cancer recurrence. British Journal of Anaesthesia. 105(2). 106–115. 351 indexed citations
16.
Greenberg, Sally & Hope S. Rugo. (2010). Challenging Clinical Scenarios: Treatment of Patients With Triple-Negative or Basal-Like Metastatic Breast Cancer. Clinical Breast Cancer. 10. S20–S29. 11 indexed citations
17.
18.
Feldt, Karen S., et al.. (2001). Providing optimal hands-on experience. A guide for clinical preceptors.. PubMed. 9(3). 71–4, 110. 2 indexed citations
19.
Brown, Arthur S., et al.. (1985). A Team Approach To Drool Control in Cerebral Palsy. Annals of Plastic Surgery. 15(5). 423–430. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura L. Benzonana Breakdown of academic impact, for papers by Paulo L. Pfitzinger Breakdown of academic impact, for papers by Deborah A. Silverman Breakdown of academic impact, for papers by Toshinari Meguro Breakdown of academic impact, for papers by Dihan Lu Breakdown of academic impact, for papers by Anna‐Laura Potthoff Breakdown of academic impact, for papers by Evert C. A. Kaal Breakdown of academic impact, for papers by Toshiaki Mishima Breakdown of academic impact, for papers by Andrej Vranič Breakdown of academic impact, for papers by J. J. Wang
Rankless by CCL
2026